Design of substrates and inhibitors of G protein-coupled receptor kinase 2 (GRK2) based on its phosphorylation reaction

被引：10
作者：
Kang, Jeong-Hun [1 ]
Toita, Riki [2 ,3 ]
Kawano, Takahito [4 ]
Murata, Masaharu [4 ]
Asai, Daisuke [5 ]
机构：
[1] Natl Cerebral & Cardiovasc Ctr Res Inst, Div Biopharmaceut & Pharmacokinet, 6-1 Shinmachi, Suita, Osaka 5648565, Japan
[2] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan
[3] Osaka Univ, Adv Photon & Biosensing Open Innovat Lab, AIST, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan
[4] Kyushu Univ, Ctr Adv Med Innovat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan
[5] St Marianna Univ, Dept Microbiol, Sch Med, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan
来源：
AMINO ACIDS | 2020年 / 52卷 / 6-7期
关键词：
G protein-coupled receptor kinase; Peptide substrate; Phosphorylation; Inhibitor; Molecular tool; BETA-ARRESTINS; PEPTIDES; COMPLEX; ASSAY; NANOPARTICLES; SELECTIVITY; ACTIVATION; PAROXETINE; EXPRESSION; RHODOPSIN;
D O I：
10.1007/s00726-020-02864-x
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The G protein-coupled receptor kinase (GRK) family consists of seven cytosolic serine/threonine (Ser/Thr) protein kinases, and among them, GRK2 is involved in the regulation of an enormous range of both G protein-coupled receptors (GPCRs) and non-GPCR substrates that participate in or regulate many critical cellular processes. GRK2 dysfunction is associated with multiple diseases, including cancers, brain diseases, cardiovascular and metabolic diseases, and therefore GRK2-specific substrates/inhibitors are needed not only for studies of GRK2-mediated cellular functions but also for GRK2-targeted drug development. Here, we first review the structure, regulation and functions of GRK2, and its synthetic substrates and inhibitors. We then highlight recent work on synthetic peptide substrates/inhibitors as promising tools for fundamental studies of the physiological functions of GRK2, and as candidates for applications in clinical diagnostics.
引用
收藏
页码：863 / 870
页数：8
相关论文
共 50 条
  • [21] Phosphorylation and regulation of a G protein-coupled receptor by protein kinase CK2
    Torrecilla, Ignacio
    Spragg, Elizabeth J.
    Poulin, Benoit
    McWilliams, Phillip J.
    Mistry, Sharad C.
    Blaukat, Andree
    Tobin, Andrew B.
    JOURNAL OF CELL BIOLOGY, 2007, 177 (01) : 127 - 137
  • [22] Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 Inhibitors
    Thal, David M.
    Yeow, Raymond Y.
    Schoenau, Christian
    Huber, Jochen
    Tesmer, John J. G.
    MOLECULAR PHARMACOLOGY, 2011, 80 (02) : 294 - 303
  • [23] Reduction of lymphocyte G protein-coupled receptor kinase-2 (GRK2) after exercise training predicts survival in patients with heart failure
    Rengo, Giuseppe
    Galasso, Gennaro
    Femminella, Grazia D.
    Parisi, Valentina
    Zincarelli, Carmela
    Pagano, Gennaro
    De Lucia, Claudio
    Cannavo, Alessandro
    Liccardo, Daniela
    Marciano, Caterina
    Vigorito, Carlo
    Giallauria, Francesco
    Ferrara, Nicola
    Furgi, Giuseppe
    Filardi, Pasquale Perrone
    Koch, Walter J.
    Leosco, Dario
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2014, 21 (01) : 4 - 11
  • [24] Small-Molecule G Protein-Coupled Receptor Kinase Inhibitors Attenuate G Protein-Coupled Receptor Kinase 2-Mediated Desensitization of Vasoconstrictor-Induced Arterial Contractions
    Rainbow, Richard D.
    Brennan, Sean
    Jackson, Robert
    Beech, Alison J.
    Bengreed, Amal
    Waldschmidt, Helen, V
    Tesmer, John J. G.
    Challiss, R. A. John
    Willets, Jonathon M.
    MOLECULAR PHARMACOLOGY, 2018, 94 (03) : 1079 - 1091
  • [25] Growth Arrest Specific 8 (Gas8) and G Protein-coupled Receptor Kinase 2 (GRK2) Cooperate in the Control of Smoothened Signaling
    Evron, Tama
    Philipp, Melanie
    Lu, Jiuyi
    Meloni, Alison R.
    Burkhalter, Martin
    Chen, Wei
    Caron, Marc G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (31) : 27676 - 27686
  • [26] Design, Synthesis, and Evaluation of the Highly Selective and Potent G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure
    Okawa, Tomohiro
    Aramaki, Yoshio
    Yamamoto, Mitsuo
    Kobayashi, Toshitake
    Fukumoto, Shoji
    Toyoda, Yukio
    Henta, Tsutomu
    Hata, Akito
    Ikeda, Shota
    Kaneko, Manami
    Hoffman, Isaac D.
    Sang, Bi-Ching
    Zou, Hua
    Kawamoto, Tetsuji
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (16) : 6942 - 6990
  • [27] Myocardial Ablation of G Protein-Coupled Receptor Kinase 2 (GRK2) Decreases Ischemia/Reperfusion Injury through an Anti-Intrinsic Apoptotic Pathway
    Fan, Qian
    Chen, Mai
    Zuo, Lin
    Shang, Xiying
    Huang, Maggie Z.
    Ciccarelli, Michele
    Raake, Philip
    Brinks, Henriette
    Chuprun, Kurt J.
    Dorn, Gerald W., II
    Koch, Walter J.
    Gao, Erhe
    PLOS ONE, 2013, 8 (06):
  • [28] The interplay between G protein-coupled receptor kinase 2 (GRK2) and histone deacetylase 6 (HDAC6) at the crossroads of epithelial cell motility
    Lafarga, Vanesa
    Mayor, Federico, Jr.
    Penela, Petronila
    CELL ADHESION & MIGRATION, 2012, 6 (06) : 495 - 501
  • [29] Inhibition of G-protein-coupled Receptor Kinase 2 (GRK2) Triggers the Growth-promoting Mitogen-activated Protein Kinase (MAPK) Pathway
    Fu, Xuebin
    Koller, Samuel
    Abd Alla, Joshua
    Quitterer, Ursula
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (11) : 7738 - 7755
  • [30] Structure-Based Design, Synthesis, and Biological Evaluation of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors
    Waldschmidt, Helen V.
    Homan, Kristoff T.
    Cruz-Rodriez, Osvaldo
    Cato, Marilyn C.
    Waninger-Saroni, Jessica
    Larimore, Kelly M.
    Cannavo, Alessandro
    Song, Jianliang
    Cheung, Joseph Y.
    Kirchhoff, Paul D.
    Koch, Walter J.
    Tesmer, John J. G.
    Larsen, Scott D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (08) : 3793 - 3807
12345